Newsroom

Sorted by: Latest

-

Evers & Sons Provides Update for NG3 Project

HOUSTON--(BUSINESS WIRE)--Evers & Sons Inc. is providing an update on the ongoing expansion of the Gillis Treating Plant, part of Momentum Midstream’s NG3 project. The facility was originally constructed to process approximately 1.7 Bcf/day of natural gas and includes treating, dehydration, compression, and associated utility systems that support the movement of gas from the Haynesville Shale to Gulf Coast markets. To support increased volumes entering the system, Evers & Sons has execu...
-

Resumen: PPG recibe la certificación REDCert² en materias primas sostenibles para dos plantas clave de Europa

ÁMSTERDAM--(BUSINESS WIRE)--PPG (NYSE: PPG) ha anunciado hoy que sus plantas de fabricación de revestimientos arquitectónicos de Ámsterdam, Países Bajos y Søborg, Dinamarca, han recibido la certificación REDCert², que constata el uso de materias primas sostenibles a lo largo de una cadena de custodia certificada. REDCert² aplica el balance de masa, un método reconocido para atribuir el valor de sostenibilidad de los insumos certificados. De ese modo, se garantiza que los productos de PPG reflej...
-

Essential Properties Realty Trust, Inc. Announces New Chief Financial Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Essential Properties Realty Trust, Inc. (NYSE: EPRT; the “Company”), today announced the appointment of Robert W. Salisbury, CFA as the Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2026. “I am pleased to announce Rob’s promotion to serve as Executive Vice President and Chief Financial Officer of the Company,” said Peter M. Mavoides, President and Chief Executive Officer of the Company. “Since joining the Company in 2...
-

Ecolab Closes Acquisition of Ovivo's Electronics Ultrapure Water Business

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. has closed on its previously announced acquisition of Ovivo's electronics ultrapure water business....
-

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which GoodRx will discuss business updates. A live webcast will be available on the Compan...
-

Apogee Enterprises Announces Date for Fiscal 2026 Third Quarter Results

MINNEAPOLIS--(BUSINESS WIRE)--Apogee Enterprises, Inc. (Nasdaq: APOG) a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, today announced the company will report its fiscal 2026 third quarter results on Wednesday, January 7, 2026, before the market opens. The Company will also host a conference call at 8:00 a.m. Central Time that day. Access to the live webcast will be available at https://www.apog.c...
-

Penguin Solutions Announces First Quarter Fiscal 2026 Conference Call

FREMONT, Calif.--(BUSINESS WIRE)--Penguin Solutions will host its quarterly financial webcast & conf call for Q1FY26 earnings after market close on Tues Jan 6 at 1:30 pm PT/4:30 pm ET...
-

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive license for the commercial rights to the combination of tobevibart and elebsiran for the treatment of chronic hepatitis delta (CHD) in Europe, Australia and New Zealand. Per the terms of the agreement, Vir Biotechnology will receive an initial reimbursement payment...
-

CRH Acquires New Jersey Business North American Aggregates

ATLANTA--(BUSINESS WIRE)--CRH today announced the acquisition of North American Aggregates (“NAA”), a leading supplier of aggregates headquartered in Perth Amboy, NJ. This strategic acquisition further expands CRH Americas Materials' aggregates business in New York and New Jersey and enhances the company’s ability to meet the long-term supply needs of customers in the region. NAA’s plant on the New Jersey waterfront brings valuable new aggregate reserves to the Tilcon NY operations along with e...
-

CareTrust REIT Announces Quarterly Dividend of $0.335 per Share

DANA POINT, Calif.--(BUSINESS WIRE)--CareTrust REIT Announces Quarterly Dividend of $0.335 per Share...